Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

ROCKEFELLER UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

The Impact of Time Restricted Eating on Type 2 Diabetes

Not Applicable

Not yet recruiting

Conditions: Type 2 Diabetes

First Posted Date: 2025-03-20

Last Posted Date: 2025-05-14

Lead Sponsor: Rockefeller University

Target Recruit Count: 10

Registration Number: NCT06887543

Locations: 🇺🇸
The Rockefeller University Hospital, New York, New York, United States

Thermogenic Silencer Regulatory Factors in Humans

Not Applicable

Recruiting

Conditions: Metabolic Disease
Obesity
Cold Exposure

Interventions: Other: Cold Vest Exposure Period
Other: Rewarming Exposure Period
Other: Fasting

First Posted Date: 2024-05-21

Last Posted Date: 2025-03-24

Lead Sponsor: Rockefeller University

Target Recruit Count: 120

Registration Number: NCT06424132

Locations: 🇺🇸
Rockefeller University, New York, New York, United States

Myokine Identification Following Acute Exercise

Not Applicable

Completed

Conditions: Adiposity

Interventions: Other: Exercise

First Posted Date: 2024-01-25

Last Posted Date: 2025-03-10

Lead Sponsor: Rockefeller University

Target Recruit Count: 12

Registration Number: NCT06223035

Locations: 🇺🇸
Rockefeller University, New York, New York, United States

Compassion-Based Resiliency Training (CBRT) Intervention on Racism-based Stress

Not Applicable

Completed

Conditions: Stress, Psychological
Racism

Interventions: Behavioral: Contemplative-Based Resilience Training (CBRT)

First Posted Date: 2023-11-24

Last Posted Date: 2025-03-20

Lead Sponsor: Rockefeller University

Target Recruit Count: 22

Registration Number: NCT06146218

Locations: 🇺🇸
Recrutment Office, New York, New York, United States

HepB MAb19 in Individuals with Chronic Hepatitis B Infection

Phase 1

Recruiting

Conditions: Hepatitis B Virus
Hepatitis B

Interventions: Other: Sterile Saline
Biological: HepB mAb19

First Posted Date: 2023-05-12

Last Posted Date: 2025-01-27

Lead Sponsor: Rockefeller University

Target Recruit Count: 37

Registration Number: NCT05856890

Locations: 🇺🇸
NYU Langone Health, New York, New York, United States
🇺🇸
The Rockefeller University, New York, New York, United States

Effect of Antibiotics on Enteric Neurons and Glia

Phase 4

Completed

Conditions: Antibiotic Enterocolitis

Interventions: Drug: Amoxicillin Oral Capsule

First Posted Date: 2023-04-28

Last Posted Date: 2024-05-22

Lead Sponsor: Rockefeller University

Target Recruit Count: 9

Registration Number: NCT05834036

Locations: 🇺🇸
Rockefeller University, New York, New York, United States

Predictors of Aspirin Failure in Preeclampsia Prevention

Early Phase 1

Recruiting

Conditions: Preeclampsia

Interventions: Drug: Aspirin

First Posted Date: 2023-02-02

Last Posted Date: 2024-05-14

Lead Sponsor: Rockefeller University

Target Recruit Count: 130

Registration Number: NCT05709483

Locations: 🇺🇸
Rockefeller University, New York, New York, United States

Racism-based and Biomarkers of Stress

Completed

Conditions: Stress, Psychological
Racism

First Posted Date: 2022-10-12

Last Posted Date: 2023-05-11

Lead Sponsor: Rockefeller University

Target Recruit Count: 20

Registration Number: NCT05574933

Locations: 🇺🇸
Rockefeller University, New York, New York, United States

HBV Vaccination of Healthy Volunteers to Evaluate the Composition of Germinal Centers

Phase 4

Recruiting

Conditions: Hepatitis B

Interventions: Biological: Hepatitis B Vaccine (Recombinant)

First Posted Date: 2022-03-09

Last Posted Date: 2025-03-19

Lead Sponsor: Rockefeller University

Target Recruit Count: 12

Registration Number: NCT05272735

Locations: 🇺🇸
The Rockefeller University, New York, New York, United States

3BNC117-LS and 10-1074-LS Plus N-803 (bNAb+N-803)

Phase 1

Active, not recruiting

Conditions: Human Immunodeficiency Virus

Interventions: Drug: 3BNC117-LS
Drug: 10-1074-LS
Drug: N803

First Posted Date: 2022-02-17

Last Posted Date: 2024-10-21

Lead Sponsor: Rockefeller University

Target Recruit Count: 28

Registration Number: NCT05245292

Locations: 🇺🇸
Weill Cornell Medicine, Cornell Clinical Trials Unit, New York, New York, United States
🇺🇸
The Rockefeller University, New York, New York, United States
🇺🇸
Perelman School of Medicine University of Pennsylvania, Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy